Jupiter Neurosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Jupiter Neurosciences, Inc. filed a supplement to its definitive proxy statement to correct scriveners' errors regarding the maximum number of shares issuable under its Standby Equity Purchase Agreement and Convertible Notes.
NASDAQ
Jupiter Neurosciences, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Jupiter Neurosciences, Inc. is seeking stockholder approval for a significant increase in authorized common stock and a $20 million equity purchase agreement to fund its operations and clinical trials.